1.Subjects willing and able to give written and dated informed consent (or legally acceptable representative/impartial witness when applicable) and is available for the entire study. <br/ > <br/ > 2.Subjects with age â?¥18 years or â?¤60 years and having Body mass index (BMI) â?¥ 17.00 calculated as weight in kg/height in m2. <br/ > <br/ > 3.Clinically diagnosed patients with Coronavirus (Covid-19) infection on the basis of RT-PCR of respiratory specimen (within 48 hours prior to randomization). <br/ > <br/ > 4.Subjects with moderate COVID-19 disease as per MoH & FW guidelines, Government of India on â??Clinical Management Protocol: COVID-19â?? as updated from time to time. i.e., pneumonia with no signs of severe disease (i.e., Adults with presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 90 to â?¤93% on room air, Respiratory Rate more or equal to 24 per minute). <br/ > <br/ > 5.Subjects with with clinically significant elevated CRP values. <br/ > <br/ > 6.Subjects with acceptable liver function: <br/ > Alanine aminotransferase (ALT) â?¤ 1.5 X ULN <br/ > Aspartate aminotransferase (AST) â?¤ 1.5 X ULN <br/ > Bilirubin < 1.5 X ULN Alkaline phosphatase â?¤ 2.5 X ULN. <br/ > <br/ > 7.Subjects with Creatinine clearance â?¥ 30 mL/minute. <br/ > <br/ > 8.Female Subjects with negative serum/urine pregnancy test at screening.

1.Subjects willing and able to give written and dated informed consent (or legally acceptable representative/impartial witness when applicable) and is available for the entire study. <br/ > <br/ > 2.Subjects with age â?¥18 years or â?¤60 years and having Body mass index (BMI) â?¥ 17.00 calculated as weight in kg/height in m2. <br/ > <br/ > 3.Clinically diagnosed patients with Coronavirus (Covid-19) infection on the basis of RT-PCR of respiratory specimen (within 48 hours prior to randomization). <br/ > <br/ > 4.Subjects with moderate COVID-19 disease as per MoH & FW guidelines, Government of India on â??Clinical Management Protocol: COVID-19â?? as updated from time to time. i.e., pneumonia with no signs of severe disease (i.e., Adults with presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 90 to â?¤93% on room air, Respiratory Rate more or equal to 24 per minute). <br/ > <br/ > 5.Subjects with with clinically significant elevated CRP values. <br/ > <br/ > 6.Subjects with acceptable liver function: <br/ > Alanine aminotransferase (ALT) â?¤ 1.5 X ULN <br/ > Aspartate aminotransferase (AST) â?¤ 1.5 X ULN <br/ > Bilirubin < 1.5 X ULN Alkaline phosphatase â?¤ 2.5 X ULN. <br/ > <br/ > 7.Subjects with Creatinine clearance â?¥ 30 mL/minute. <br/ > <br/ > 8.Female Subjects with negative serum/urine pregnancy test at screening.